(1)

On 1 August 2011, the Council adopted Regulation (EU) No 753/2011.

(2)

On 2 November 2015, the United Nations Security Council Committee established pursuant to paragraph 30 of UN Security Council Resolution 1988 (2011) amended the list of individuals, groups, undertakings and entities subject to restrictive measures.

(3)

Annex I to Regulation (EU) No 753/2011 should therefore be amended accordingly,

(1)

On 26 April 2010, the Council adopted Regulation (EU) No 356/2010.

(2)

On 11 March 2014, the United Nations Security Council Committee established pursuant to United Nations Security Council Resolution (UNSCR) 751 (1992) and UNSCR 1907 (2009) deleted one person from the list of persons subject to the restrictive measures set out in paragraphs 1, 3 and 7 of UNSCR 1844 (2008).

(3)

Annex I to Regulation (EU) No 356/2010 should therefore be amended accordingly,

(1)

Pursuant to Article 50(2)(b) of Regulation (EU) No 1151/2012, Latvia's application to register the name ‘Jāņu siers’ was published in the Official Journal of the European Union (2).

(2)

As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Jāņu siers’ should therefore be entered in the register,

(1)

In accordance with Article 23(3) of Regulation (EC) No 1107/2009, the Commission received on 26 April 2013 an application from the Institut Technique de l'Agriculture Biologique (ITAB), for the approval of Artemisia absinthium L. as basic substance. That application was accompanied by the information required under the second subparagraph of Article 23(3).

(2)

The Commission asked the European Food Safety Authority (hereinafter ‘the Authority’) for scientific assistance. The Authority presented to the Commission a Technical Report on the substance concerned on 30 September 2014 (2). The Commission presented the review report (3) and the draft of this Regulation on the non-approval of Artemisia absinthium L. to the Standing Committee on Plants, Animals, Food and Feed on 20 March 2015.

(3)

The documentation provided by the applicant shows that Artemisia absinthium L. fulfils the criteria of a foodstuff as defined in Article 2 of Regulation (EC) No 178/2002 of the European Parliament and of the Council (4). However, alcoholic beverages from Artemisia species are included in Part B of Annex III to Regulation (EC) No 1334/2008 of the European Parliament and of the Council (5), which sets maximum levels of certain substances, naturally present in flavourings and food ingredients with flavouring properties, in certain compound food as consumed to which flavourings and/or food ingredients with flavouring properties have been added. According to Article 6 of Regulation (EC) No 1334/2008, in the compound foods listed in that Part B, the maximum levels are not to be exceeded as a result of the use of flavourings and/or food ingredients with flavouring properties. The Artemisia species can therefore not be used as a foodstuff without qualification.

(4)

Specific concerns were identified, in the Technical Report of the Authority, regarding exposure to thujone, absinthin and ferulic acid and, as a result, the assessment of the risk to operators, workers, bystanders, consumers and non-target organisms could not be finalised.

(5)

The Commission invited the applicant to submit its comments on the Technical Report of the Authority and on the draft review report. The applicant submitted its comments, which have been carefully examined.

(6)

However, despite the arguments put forward by the applicant, the concerns related to the substance cannot be eliminated.

(7)

Consequently, as laid down in the Commission review report, it has not been established that the requirements laid down in Article 23 of Regulation (EC) No 1107/2009 are satisfied. It is therefore appropriate not to approve Artemisia absinthium L. as basic substance.

(8)

This Regulation does not prejudice the submission of a further application for the approval of Artemisia absinthium L. as basic substance in accordance with Article 23(3) of Regulation (EC) No 1107/2009.

(9)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

(1)

The approval of the active substance esfenvalerate, as set out in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2), expires on 30 June 2016.

(2)

An application for the renewal of the inclusion of esfenvalerate in Annex I to Council Directive 91/414/EEC (3) was submitted in accordance with Article 4 of Commission Regulation (EU) No 1141/2010 (4) within the time period provided for in that Article.

(3)

The applicant submitted the supplementary dossiers required in accordance with Article 9 of Regulation (EU) No 1141/2010. The application was found to be complete by the rapporteur Member State.

(4)

The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (hereinafter ‘the Authority’) and the Commission on 30 July 2013.

(5)

The Authority communicated the renewal assessment report to the applicant and to the Member States for comments and forwarded the comments received to the Commission. The Authority also made the supplementary summary dossier available to the public.

(6)

On 22 October 2014 the Authority communicated to the Commission its conclusion (5) on whether esfenvalerate can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Commission presented the draft review report for esfenvalerate to the Standing Committee on Plants, Animals, Food and Feed on 20 March 2015.

(7)

It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance that the approval criteria provided for in Article 4 are satisfied. Those approval criteria are therefore deemed to be satisfied.

(8)

The risk assessment for the renewal of the approval of esfenvalerate is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing esfenvalerate may be authorised. It is therefore appropriate not to maintain the restriction to uses as an insecticide.

(9)

The Commission however considers that esfenvalerate is a candidate for substitution pursuant to Article 24 of Regulation (EC) No 1107/2009. Esfenvalerate is a toxic substance in accordance with points 3.7.2.2 and 3.7.2.3 respectively, of Annex II to Regulation (EC) No 1107/2009, given that bioconcentration factor is greater than 2 000 and the long-term no-observed effect concentration for freshwater organisms is less than 0,01 mg/L. Esfenvalerate therefore fulfils the condition set in the second indent of point 4 of Annex II to Regulation (EC) No 1107/2009.

(10)

It is therefore appropriate to renew the approval of esfenvalerate as a candidate for substitution.

(11)

In accordance with Article 20(3) of Regulation (EC) No 1107/2009, in conjunction with Article 13(4) thereof, the Annex to Implementing Regulation (EU) No 540/2011 should be amended accordingly.

(12)

Commission Implementing Regulation (EU) 2015/1885 (6) extended the expiry date of esfenvalerate to allow the renewal process to be completed before the expiry of the substance. However, given that a decision on renewal has been taken ahead of the original expiry date, this Regulation should apply from the day after the original date of expiry.

(13)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

(1)

Implementing Regulation (EU) No 543/2011 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations, the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products and periods stipulated in Annex XVI, Part A thereto.

(2)

The standard import value is calculated each working day, in accordance with Article 136(1) of Implementing Regulation (EU) No 543/2011, taking into account variable daily data. Therefore this Regulation should enter into force on the day of its publication in the Official Journal of the European Union,

(1)

According to Article 25(2) of Decision 2008/615/JHA, the supply of personal data provided for under that Decision may not take place until the general provisions on data protection set out in Chapter 6 of that Decision have been implemented in the national law of the territories of the Member States involved in such supply.

(2)

Article 20 of Council Decision 2008/616/JHA (2) provides that the verification that the above condition has been met with respect to automated data exchange in accordance with Chapter 2 of Decision 2008/615/JHA is to be done on the basis of an evaluation report based on a questionnaire, an evaluation visit and a pilot run.

(3)

According to Chapter 4, point 1.1, of the Annex to Decision 2008/616/JHA, the questionnaire drawn up by the relevant Council working group concerns each of the automated data exchanges and has to be answered by a Member State as soon as it believes it fulfils the prerequisites for sharing data in the relevant data category.

(4)

Sweden has completed the questionnaire on data protection and the questionnaire on dactyloscopic data exchange.

(5)

A successful pilot run has been carried out by Sweden with Austria.

(6)

An evaluation visit has taken place in Sweden and a report on the evaluation visit has been produced by the Austrian evaluation team and forwarded to the relevant Council working group.

(7)

An overall evaluation report, summarising the results of the questionnaire, the evaluation visit and the pilot run concerning dactyloscopic data exchange, has been presented to the Council.

(8)

On 13 July 2015, the Council concluded that Sweden had fully implemented the general provisions on data protection set out in Chapter 6 of Decision 2008/615/JHA.

(9)

Therefore, for the purposes of automated searching of dactyloscopic data, Sweden should be entitled to receive and supply personal data pursuant to Article 9 of Decision 2008/615/JHA.

(10)

Denmark is bound by Decision 2008/615/JHA and is therefore taking part in the adoption and application of this Decision which implements Decision 2008/615/JHA.

(11)

Ireland is bound by Decision 2008/615/JHA and is therefore taking part in the adoption and application of this Decision which implements Decision 2008/615/JHA.

(12)

The United Kingdom is not bound by Decision 2008/615/JHA and is therefore not taking part in the adoption of this Decision which implements Decision 2008/615/JHA and is not bound by it or subject to its application,

(1)

According to Article 25(2) of Decision 2008/615/JHA, the supply of personal data provided for under that Decision may not take place until the general provisions on data protection set out in Chapter 6 of that Decision have been implemented in the national law of the territories of the Member States involved in such supply.

(2)

Article 20 of Council Decision 2008/616/JHA (2) provides that the verification that the above condition has been met with respect to automated data exchange in accordance with Chapter 2 of Decision 2008/615/JHA is to be done on the basis of an evaluation report based on a questionnaire, an evaluation visit and a pilot run.

(3)

According to Chapter 4, point 1.1, of the Annex to Decision 2008/616/JHA, the questionnaire drawn up by the relevant Council working group concerns each of the automated data exchanges and has to be answered by a Member State as soon as it believes it fulfils the prerequisites for sharing data in the relevant data category.

(4)

Belgium has completed the questionnaire on data protection and the questionnaire on dactyloscopic data exchange.

(5)

A successful pilot run has been carried out by Belgium with France and Luxembourg.

(6)

An evaluation visit has taken place in Belgium and a report on the evaluation visit has been produced by the French and Luxembourgish evaluation team and forwarded to the relevant Council working group.

(7)

An overall evaluation report, summarising the results of the questionnaire, the evaluation visit and the pilot run concerning dactyloscopic data exchange, has been presented to the Council.

(8)

On 13 July 2015, the Council concluded that Belgium had fully implemented the general provisions on data protection set out in Chapter 6 of Decision 2008/615/JHA.

(9)

Therefore, for the purposes of automated searching of dactyloscopic data, Belgium should be entitled to receive and supply personal data pursuant to Article 9 of Decision 2008/615/JHA.

(10)

Denmark is bound by Decision 2008/615/JHA and is therefore taking part in the adoption and application of this Decision which implements Decision 2008/615/JHA.

(11)

Ireland is bound by Decision 2008/615/JHA and is therefore taking part in the adoption and application of this Decision which implements Decision 2008/615/JHA.

(12)

The United Kingdom is not bound by Decision 2008/615/JHA and is therefore not taking part in the adoption of this Decision which implements Decision 2008/615/JHA and is not bound by it or subject to its application,

(1)

Council Decision 2013/730/CFSP (1) provides that the Union shall contribute to the South-Eastern and Eastern Europe Clearinghouse for the Control of Small Arms and Light Weapons (SEESAC) Project on Reducing the Threat of the Illicit Spread and Trafficking of Small Arms and Light Weapons (SALW) and their Ammunition in South East Europe.

(2)

The project supported by Decision 2013/730/CFSP aims, amongst other aspects, to improve the security provisions and stockpile management for the storage of conventional weapons and ammunition stockpiles (the ‘storage security component’).

(3)

In paragraph 3.1 of the Annex to Decision 2013/730/CFSP, Bosnia and Herzegovina, Kosovo (*1), the Republic of Moldova, Montenegro, Serbia and the former Yugoslav Republic of Macedonia (FYROM) are designated as beneficiaries of the storage security component, however Albania is not.

(4)

According to the implementing agency SEESAC, and with the agreement of the Albanian authorities, there is a need for Albania to benefit from the storage security component and there is available funding under Decision 2013/730/CFSP.

(5)

Decision 2013/730/CFSP should, therefore, be amended to include Albania as a beneficiary of the storage security component,

(1)

On 25 January 2012, the Council adopted Decision 2012/39/CFSP (1) appointing Mr Samuel ŽBOGAR as the European Union Special Representative (EUSR) in Kosovo. The mandate of the EUSR was last amended by Council Decision 2014/400/CFSP (2). The mandate of the EUSR is to expire on 31 October 2015.

(2)

The mandate of the EUSR should be extended for a further period of 16 months.

(3)

The EUSR will implement the mandate in the context of a situation which may deteriorate and could impede the achievement of the objectives of the Union's external action as set out in Article 21 of the Treaty on European Union.

(4)

Any possible alterations to the tasks and objectives of the European Union Rule of Law Mission in Kosovo (EULEX KOSOVO) having an impact on the tasks and objectives of the EUSR should be considered, in relation to the EUSR's mandate, as appropriate in due course,

(a)

offer the Union's advice and support in the political process;

(b)

promote overall Union political coordination in Kosovo;

(c)

strengthen the presence of the Union in Kosovo and ensure its coherence and effectiveness;

(d)

provide local political guidance to the Head of EULEX KOSOVO, including on the political aspects of issues relating to executive responsibilities;

(e)

ensure consistency and coherence of Union action in Kosovo, including in guiding locally the EULEX transition;

(f)

support Kosovo's European perspective and rapprochement with the Union in line with the perspective of the region and in accordance with the Stabilisation and Association Agreement and the Council Decision on its signing, and in line with the relevant Council Conclusions, through targeted public communication and Union outreach activities designed to ensure a broader understanding and support from the Kosovo public on issues related to the Union, including the work of EULEX;

(g)

monitor, assist and facilitate progress on political, economic and European priorities, in line with respective institutional competencies and responsibilities;

(h)

contribute to the development and consolidation of respect for human rights and fundamental freedoms in Kosovo, including with regard to women and children and protection of minorities, in accordance with the Union's human rights policy and Union Guidelines on Human Rights;

(i)

assist in the implementation of the Belgrade-Pristina dialogue facilitated by the Union.

(a)

establishing a specific security plan based on guidance from the EEAS, including specific physical, organisational and procedural security measures, governing the management of the secure movement of personnel to, and within, the area of responsibility, as well as the management of security incidents and a contingency and evacuation plan;

(b)

ensuring that all personnel deployed outside the Union are covered by high risk insurance as required by the conditions in the area of responsibility;

(c)

ensuring that all members of the EUSR's team to be deployed outside the Union, including locally contracted personnel, have received appropriate security training before or upon arriving in the area of responsibility, based on the risk ratings assigned to that area by the EEAS;

(d)

ensuring that all agreed recommendations made following regular security assessments are implemented, and providing the Council, the HR and the Commission with written reports on their implementation and on other security issues within the framework of the progress and mandate implementation reports.

(1)

On 26 April 2010, the Council adopted Decision 2010/231/CFSP.

(2)

On 11 March 2014, the United Nations Security Council Committee established pursuant to United Nations Security Council Resolution (UNSCR) 751 (1992) and UNSCR 1907 (2009) deleted one person from the list of persons subject to the restrictive measures set out in paragraphs 1, 3 and 7 of UNSCR 1844 (2008).

(3)

Annex I to Decision 2010/231/CFSP should therefore be amended accordingly,

(1)

On 1 August 2011, the Council adopted Decision 2011/486/CFSP.

(2)

On 2 November 2015, the United Nations Security Council Committee established pursuant to paragraph 30 of UN Security Council Resolution 1988 (2011) amended the list of individuals, groups, undertakings and entities subject to restrictive measures.

(3)

The Annex to Decision 2011/486/CFSP should therefore be amended accordingly,

(1)

Directive 92/119/EEC lays down general measures for the control of certain animal diseases. These include measures to be taken in the event of a suspicion and the confirmation of lumpy skin disease (LSD) in a holding, the measures to be taken in restriction zones and other additional measures to control the disease. Those measures also provide for emergency vaccination in case of an outbreak of LSD as a supplement to other control measures.

(2)

On 20 August 2015, the Greek authorities notified the Commission of two outbreaks of LSD in bovine holdings with approximately 200 bovine animals in Feres area of the regional unit of Evros in Greece. These outbreaks represent the first occurrence of LSD in the Union.

(3)

In order to prevent the spread of LSD to other parts of Greece, to other Member States and to third countries, the Commission adopted Commission Implemening Decision (EU) 2015/1423 (5) prohibiting the movement and dispatch of bovine animals and semen thereof, as well as the placing on the market of certain animal products from the regional unit of Evros.

(4)

In the light of further information on the epidemiological situation in Greece those interim protective measures were replaced by the more complex protection measures laid down in Commission Implemening Decision (EU) 2015/1500 (6).

(5)

Moreover, on 10 September 2015 Greece informed the Commission and Member States about 24 confirmed and 17 suspected outbreaks of LSD on holdings situated in the established protection and surveillance zones in the regional unit of Evros.

(6)

Additionally, on 27 September 2015, the Greek authorities notified the Commission of an outbreak of LSD in the South-East of the regional unit of Xanthi and again, on 2 October 2015, of a new outbreak of LSD in the regional unit of Kavala, located west of the regional unit of Xanthi.

(7)

Furthermore, on 7 October 2015 the Greek authorities notified the Commission of an outbreak of LSD in one bovine holding in the regional unit of Limnos.

(8)

In the event of an outbreak of LSD, Article 19 of Directive 92/119/EEC provides for the possibility to apply vaccination against that disease.

(9)

On 26 August 2015 Greece submitted to the Commission a programme for emergency vaccination against LSD of bovine animals kept on holdings in the regional unit of Evros in Greece. The programme provided details concerning the geographical and administrative definition of the vaccination zone, the number of holdings and animals to be vaccinated and the time when vaccination should be accomplished and the circumstances motivating the decision to implement the measures.

(10)

In accordance with the Scientific Opinion of the European Food Safety Authority (the EFSA) on lumpy skin disease (7) only live attenuated vaccines against LSD are commercially available. The opinion describes the Neethling attenuated LSD virus vaccine as highly effective in preventing morbidity. Because homologous LSD vaccines are more effective than vaccines based on attenuated sheep pox viruses, their use is to be recommended, subject to availability by vaccine producers which are exclusively operating outside the Union.

(11)

There is no vaccine against LSD with the marketing authorisation in the Union. Emergency vaccination in accordance with Article 19 of Directive 92/119/EEC can therefore only be carried out in accordance with Article 8 of Directive 2001/82/EC of the European Parliament and of the Council (8), permitting Member States to provisionally allow the use of vaccines without a marketing authorisation in the event of a serious epizootic disease as it is the case of LSD.

(12)

In accordance with Article 19(6) of Directive 92/119/EEC, Greece informed the Commission on 5 September 2015 of the acquisition of a sufficient number of doses of homologous LSD vaccine and the start of emergency vaccination in protection and surveillance zones in the regional unit of Evros according to the vaccination programme described in recital 9. In addition, on 27 September and 2 October 2015 respectively, the Greek authorities informed the Commission of their decision to introduce vaccination of bovine animals kept on holdings in the regional units of Rodopi, Xanthi and Kavala in line with the vaccination programme submitted on 26 August 2015.

(13)

The purpose of this Decision is to define the conditions under which Greece should apply emergency vaccination. The rapid spread of LSD in Greece constitutes a risk to other parts of the territory of Greece and to neighbouring countries. Therefore, it is also the purpose of this Decision to reinforce the disease control measures applied in Greece by restricting the movement of unvaccinated bovine animals older than 3 months to other holdings within the restricted area. This age limitation allows the necessary movement of young calves to other holdings for further rearing during a period after birth when they cannot be effectively immunised. At the same time, it is necessary to allow the movement of unvaccinated animals directly to a slaughterhouse within the restricted area.

(14)

The area where vaccination against LSD is to be carried out may cover the entire restricted zone as defined in Implementing Decision (EU) 2015/1500, which is set out in the Annex to that Decision.

(15)

The first round of vaccination should be completed as soon as possible and not later than 31 October 2015 and 30 November 2015 in the regional unit of Evros and in the regional units of Rodopi, Xanthi and Kavala respectively. In case of further outbreaks in other regional units, the vaccination in the affected regional unit should be completed within 2 months after the confirmation of the first outbreak of LSD in that regional unit subject to availability of vaccines. Because the success of the control measures in Greece also depends on the success of the control measures in a neighbouring third country which had reported outbreaks of LSD in close proximity to those notified in Greece, it may be necessary to vaccinate offspring born to vaccinated bovine animals and to revaccinate bovine animals in the affected area. The period of application of this Decision on vacination against LSD in Greece has therefore been set until the end of 2016.

(16)

The risk of spreading the disease from vaccinated animals and products thereof is different to the risks arising from non-vaccinated and possibly incubating animals. Therefore, it is necessary to lay down conditions for the movement of vaccinated bovine animals and for the placing on the market of products derived from such animals.

(17)

The knowledge about LSD is incomplete. Vaccinated bovine animals are protected from clinical signs but not necessarily from infection and not all vaccinated animals respond with a protective immunity. Therefore, such animals after the period of at least 28 days following the vaccination shall be allowed to be sent directly for immediate slaughter to slaughterhouses situated on the territory of Greece.

(18)

Consequently, fresh meat and meat preparations thereof, as well as meat products subjected to a non-specific treatment may constitute a non-negligible risk of spreading LSD. Therefore, it is justified to limit the placing on the market of the fresh meat, meat preparations and meat products thereof to the territory of Greece, provided that such fresh meat, meat preparations and meat products are subjected to special marking which is not oval and cannot be confused with the health mark for fresh meat as set out in Chapter III of Section I of Annex I to Regulation (EC) No 854/2004 of the European Parliament and of the Council (9) and the identification mark for meat preparations and meat products consisting of or containing meat of bovine animals, as set out in Section I of Annex II to Regulation (EC) No 853/2004 of the European Parliament and of the Council (10).

(19)

However, a specific treatment of meat products in hermetically sealed containers to a Fo value of three or more and a treatment described in points 1.1 to 1.5 of Part A of Annex IX to Council Directive 2003/85/EC (11) of milk and dairy products sufficiently inactivate LSD virus in such products destined for human consumption and therefore such milk and dairy products should be allowed to be placed on the market on the whole of the teritorry of Greece and in other Member States and to be dispatched to third countries.

(20)

Implementing Decision (EU) 2015/1500 should therefore be amended accordingly.

(21)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

(1)

in Article 1, paragraph 3 is deleted;

(2)

in Article 4, paragraph 1, is replaced by the following:

(3)

Article 5 is replaced by the following:

(*1)  Commission Regulation (EC) No 599/2004 of 30 March 2004 concerning the adoption of a harmonised model certificate and inspection report linked to intra-Community trade in animals and products of animal origin (OJ L 94, 31.3.2004, p. 44).’ "

(4)

Article 6 is replaced by the following:

(5)

Article 7 is replaced by the following:

(*2)  Council Directive 2003/85/EC of 29 September 2003 on Community measures for the control of foot-and-mouth disease repealing Directive 85/511/EEC and Decisions 89/531/EEC and 91/665/EEC and amending Directive 92/46/EEC (OJ L 306, 22.11.2003, p. 1).’ "

(6)

the title of Article 8 is replaced by the following:

‘Article 8

Special marking of fresh meat, meat preparations and meat products referred to in Articles 5(1) and 6(2) respectively’

(7)

the date in Article 12 is replaced by ‘31 December 2016’.

(8)

the Annex is replaced by the text in Annex III.

(1)

Commission Decision 2009/300/EC (2) expires on 31 December 2015.

(2)

Commission Decision 2009/563/EC (3) expires on 31 December 2015.

(3)

Commission Decision 2009/894/EC (4) expires on 31 December 2015.

(4)

Commission Decision 2011/330/EU (5) expires on 31 December 2015.

(5)

Commission Decision 2011/337/EU (6) expires on 31 December 2015.

(6)

An assessment has been carried out confirming the relevance and appropriateness of the current ecological criteria, as well as of the related assessment and verification requirements, established by Decisions 2009/300/EC, 2009/563/EC, 2009/894/EC, 2011/330/EU and 2011/337/EU. As the current ecological criteria and the related assessment and verification requirements set out in those Decisions are still under revision, it is appropriate to prolong the periods of validity of those ecological criteria and those related assessment and verification requirements until 31 December 2016.

(7)

Decisions 2009/300/EC, 2009/563/EC, 2009/894/EC, 2011/330/EU and 2011/337/EU should therefore be amended accordingly.

(8)

The measures provided for in this Decision are in accordance with the opinion of the Committee set up by Article 16 of Regulation (EC) No 66/2010,

(1)

Commission Implementing Decision 2013/413/EU (2) authorises derogations from certain provisions of Directive 2000/29/EC in respect of potatoes, other than potatoes intended for planting, originating in the regions of Akkar and Bekaa of Lebanon for a limited period and subject to specific conditions.

(2)

Some Member States have asked for an extension of the authorisation to derogate provided by Implementing Decision 2013/413/EU.

(3)

Since the circumstances justifying those derogations still apply and there is neither new information giving cause for revision of the specific conditions nor any risk of spreading harmful organisms, the authorisation for derogations should be extended by three years.

(4)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed.

(1)

Commission Implementing Decision (EU) 2015/144 (2) lays down the procedures for the submission of applications for grants and requests for payment, and the information relating thereto, in respect of emergency measures against animal diseases listed in Annex I to Regulation (EU) No 652/2014.

(2)

In the Bulgarian, Czech, Danish, Dutch, English, Estonian, Finnish, German, Greek, Hungarian, Italian, Latvian, Maltese, Polish, Portuguese, Romanian, Slovak, Slovenian, Spanish and Swedish language versions of Implementing Decision (EU) 2015/144, the first paragraph of Article 1 refers to ‘diseases listed in Annex I to that Regulation’. As it is not indicated in those language versions to which Regulation Annex I belongs, clarification is necessary by making a clear reference to Regulation (EU) No 652/2014. In addition, in the Croatian language version that paragraph has a different wording that also refers to Article 6(1) of Regulation (EU) No 652/2014. Therefore, the Croatian language version needs to be aligned to the other language versions.

(3)

Article 3(b) of Implementing Decision (EU) 2015/144 provides that Member States are to submit to the Commission detailed information on the costs supporting the request for payment and on the costs made and paid for the different categories of eligible expenditure in accordance with the template set out in Annex IV to that Implementing Decision. In order to adapt that template to that requirement, it is necessary to introduce into the Section entitled ‘Operational — Request for reimbursement’ a new category which provides the details of the costs for purchase, storage, administration, distribution of vaccines and baits as well as costs of inoculation itself. Furthermore, that Section should be renamed ‘Operational costs — request for payment’ in accordance with Regulation (EU) No 652/2014.

(4)

Implementing Decision (EU) 2015/144, and Annex IV to Implementing Decision (EU) 2015/144 should therefore be amended and corrected accordingly.

(5)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,